Search for: "In re: DARVOCET, DARVON, AND PROPOXYPHENE PRODUCTS LIABILITY LITIGATION" Results 1 - 20 of 33
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Mass. 2017) (citing In re Darvocet, Darvon, and Propoxyphene Products Liability Litigation, 756 F.3d 917, 938-939 (6th Cir. 2014)). [2] 407 P.3d 18, 29 (Cal. 2017). [3] Id. at 47. [4] Rafferty v. [read post]
23 Nov 2015, 8:59 am
  The decision is In re Yasmin & Yaz (Drospirenone) Marketing, Sales Practices & Products Liability Litigation, 2015 WL 7272766 (S.D. [read post]
13 Nov 2015, 4:54 am
”  Id. at *4 & n.4 (citing In re Darvocet, Darvon, & Propoxyphene Products Liability Litigation, 756 F.3d 917, 934 (6th Cir. 2014); Moore v. [read post]
31 Dec 2014, 5:00 am
                  In re Darvocet, Darvon, & Propoxyphene Products Liability Litigation, 756 F.3d 917 (6th Cir. 2014). [read post]
27 Oct 2014, 2:28 am by Brian Wolfman
Recently, in In re Darvocet, Darvon, and Propoxyphene Products Liability Litigation, 756 F.3d 917 (2014), the Sixth Circuit, interpreting the law of twenty-two states, joined the majority view. [read post]
22 Aug 2014, 9:22 am
  The claims in In re Darvocet, Darvon, & Propoxyphene Products Liability Litigation, ___ F.3d ___, 2014 WL 2959271 (6th Cir. [read post]
18 Jul 2014, 11:55 am
  In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 2012 WL 3842045, at *7-8 (E.D. [read post]
1 Jul 2014, 1:08 am by FDABlog HPM
Court of Appeals for the Sixth Circuit issued its decision in In re Darvocet, Darvon, & Propoxyphene Products Liability Litigation, Case Nos. 12-5368, et al. (6th Cir. [read post]
30 Jun 2014, 6:07 am by Colter Paulson
It’s been more than two years since we reported on the appeal in the Darvocet MDL (In re: Darvocet, Darvon and Propoxyphene Products Liability Litigation, No. 11-md-2226-DCR, MDL 2226), which involves claims against generic manufacturers of a generic equivalent of the drug Darvon. [read post]
27 Jun 2014, 9:43 am
  The opinion involves 68 plaintiffs and the law in 22 states.Here’s a link to the opinion, which is encaptioned In re Darvocet, Darvon, & Propoxyphene Products Liability Litigation, Nos. 12-5368, et al. (6th Cir. [read post]
9 Aug 2013, 6:08 am by Sean Wajert
See In Re: Darvocet, Darvon and Propoxyphene Products Liability Litigation, No. 2:11-md-02226 (E.D. [read post]
6 Aug 2013, 12:18 pm by Michelle Yeary
  In re Darvocet, Darvon and Propoxyphene Products Liability Litigation, MDL 2226, 2013 U.S. [read post]
25 Apr 2013, 5:00 am by Bexis
Ohio 2009) warranty; privityIn re Zyprexa Products Liability Litigation, 649 F. [read post]
1 Feb 2013, 9:42 am by Bexis
  Back in May, 2010 we first applied that description to In re Gadolinium-Based Contrast Agents Products Liability Litigation, 2010 WL 1796334 (N.D. [read post]
18 Jan 2013, 2:06 pm by Bexis
 Such disincentive is the necessary byproduct of divorcing product liability from product manufacturing. [read post]
28 Dec 2012, 1:57 pm by Bexis
  We did, and we’re back just in time for our favorite (and nearly last) post of the year, our choices for the best prescription medical product liability decisions of 2012. [read post]
27 Dec 2012, 3:47 pm by Bexis
In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 2012 WL 718618, at *3 (E.D. [read post]